Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT-2 Inhibitors as Adjuvant Therapy With Letrozole in PCOS
NCT07589075Phase 4Completed
- Sponsor
- Beni Suef University
- Start
- Oct 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in polycystic ovary syndrome (PCOS), sponsored by Beni Suef University. Started Oct 2023; status: completed.
02
Drugs
dapagliflozin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07589075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07589075.